Brown-launched biotech secures $375,000 in Slater funding

XM Therapeutics seeks to develop new treatments for chronic heart and pulmonary conditions.

By: Jacquelyn Voghel

Published in Providence Business News

A biotech company with roots in Brown University has secured $375,000 from the Slater Technology Fund to support the creation of lab-developed biological structures that treat chronic heart and respiratory diseases.

XM Therapeutics, which spun out from Brown University in 2022 and is currently raising seed funding, focuses on the body’s extracellular matrix, a network of proteins and scaffolds that powers cell creation, growth and repairs to all body tissues and organs. In people with certain chronic illnesses, the ECM structure can’t carry out this usual healing and repair processes, leading to inflammation, scarring and poor oxygen supply.

Read the full Providence Business News story here.